Thyroid News and Research

RSS

Novel way to immobilise radioactive iodine

A novel way to immobilise radioactive forms of iodine using a microwave, has been discovered by an expert at the University of Sheffield.

26 May 2011

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

A new study by Baylor University environmental health researchers found that zebra fish exposed to several different technical mixtures of polybrominated diphenyl ethers (PBDEs) - a common fire retardant - during early development can cause developmental malformations, changes in behavior and death.

25 May 2011

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.

24 May 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.

24 May 2011

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.

20 May 2011

Bioengineering students redesign pediatric mannequin

Rice University bioengineering students have modified a child-size training mannequin to give medical students hands-on pediatric experience so that real patients can be spared further stress and pain.

17 May 2011

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.

17 May 2011

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

For diagnosing head and neck ailments, tests that use radiation are always less desirable than those that don't. Otolaryngologists have a wide range of techniques available to them, including CT or "CAT" scans, MRI and ultrasound.

12 May 2011

Study evaluates link between thyroid autoantibodies, miscarriage and preterm birth

GW Researcher Dr. Alex Stagnaro-Green, and colleagues, have contributed an editorial featured in the May 14 issue of the British Medical Journal reviewing a study that evaluated the relationship between thyroid autoantibodies and both miscarriage and preterm birth.

11 May 2011

University of California, Irvine Medical Center introduce Journal of Adolescent and Young Adult Oncology

A new effort led by a University of California, Irvine Medical Center oncologist seeks to improve cancer survival for adolescents and young adults. Dr. Leonard S. Sender has long advocated changing the approach oncologists take when treating patients and survivors aged 15 to 39.

7 May 2011

TPO antibodies linked to abnormal thyroid levels in women after giving birth

Almost 1 in 20 women who gives birth will go on to develop thyroid problems within two years, according to a new study presented at the European Congress of Endocrinology in Rotterdam. This could have significant implications for the future health of the mother and child, as well as potentially presenting problems for future pregnancies.

4 May 2011

Porter Adventist Hospital introduces new institute for robotic surgery

Robotic surgery, once the stuff of science fiction, has for some years been recognized as an important advance in surgical technique and patient experience. Now, at Porter Adventist Hospital, a comprehensive team of surgeons and staff are helping to bring in a new era in robotic surgery.

2 May 2011

Study reveals dangerous chemicals in foam carpet pads

In the first public study of its kind, a type of foam carpet pad commonly sold in the USA was demonstrated to contain flame retardant chemicals that raise concerns about human health. Lowered IQ's in children exposed in utero, infertility, and cancer are among health effects linked to exposure from these halogenated chemicals.

29 Apr 2011

Health effects of Chernobyl nuclear crisis remain unknown 25 years after incident

Though it has been 25 years since a disastrous explosion at the Chernobyl nuclear power plant in Ukraine sent radioactive material into the air, affecting Russia, Ukraine and Belarus, as well as the rest of the world, "experts are still debating the long-term health effects of the disaster," the Los Angeles Times' "Booster Shots" blog reports.

28 Apr 2011

Alkem, Karo Bio partner to license eprotirome

Karo Bio has entered into a collaboration and license agreement with the Indian pharmaceutical company Alkem Laboratories Ltd.

26 Apr 2011

AstraZeneca selects Biologics as U.S. channel partner for vandetanib

Biologics, Inc., an integrated oncology management company, is pleased to announce it has been selected by AstraZeneca as the exclusive U.S. strategic channel partner for vandetanib.

25 Apr 2011

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca today announced that the orphan drug vandetanib is now available to U.S. patients for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

25 Apr 2011

Worm protein controls key aspects of secretion of growth factors out of cells

Research in the worm is shedding light on a protein associated with a number of different human cancers, and may point to a highly targeted way to treat them.

22 Apr 2011

Fleming ramps up production of ThyroShield to meet increased domestic and international demand

Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.

22 Apr 2011

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

The world must prepare for more major nuclear accidents, U.N. Secretary-General Ban Ki-moon said on Wednesday at a Kiev conference marking the explosion of a reactor at Ukraine's Chernobyl nuclear reactor 25 years ago, the Associated Press reports.

22 Apr 2011

Thyroid News and Research

Novel way to immobilise radioactive iodine

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

Bioengineering students redesign pediatric mannequin

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

Study evaluates link between thyroid autoantibodies, miscarriage and preterm birth

University of California, Irvine Medical Center introduce Journal of Adolescent and Young Adult Oncology

TPO antibodies linked to abnormal thyroid levels in women after giving birth

Porter Adventist Hospital introduces new institute for robotic surgery

Study reveals dangerous chemicals in foam carpet pads

Health effects of Chernobyl nuclear crisis remain unknown 25 years after incident

Alkem, Karo Bio partner to license eprotirome

AstraZeneca selects Biologics as U.S. channel partner for vandetanib

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

Worm protein controls key aspects of secretion of growth factors out of cells

Fleming ramps up production of ThyroShield to meet increased domestic and international demand

Also in global health news: Nuclear accidents; measles outbreak in Europe; funding shortfall in Zimbabwe; drinking water in Pakistan; agricultural development in S. Asia

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News